Jiangsu Apon Medical Technology Co., Ltd. (SHE:300753)
China flag China · Delayed Price · Currency is CNY
19.69
+0.29 (1.49%)
Oct 28, 2026, 2:05 PM CST

SHE:300753 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
319.44339.37402.3420.79323.38460.72
Other Revenue
2.652.651.51.380.430.49
322.09342.02403.8422.17323.81461.21
Revenue Growth
-15.39%-15.30%-4.35%30.38%-29.79%4.09%
Cost of Revenue
102110.4127.74145.71163.82166.33
Gross Profit
220.09231.62276.06276.46159.99294.88
Selling, General & Admin
209.5227.85231.61228.59207.17199.73
Research & Development
43.6940.5633.2836.5534.9543.98
Other Operating Expenses
6.06-4.73-13.03-8.28-2.53-3.78
Operating Expenses
254.12261.15258.06264.8240.71246.76
Operating Income
-34.03-29.531811.66-80.7248.12
Interest Expense
-0.91-3.26-3.07-3.04-2.47-1.13
Interest & Investment Income
-2.041.982.273.514.46
Currency Exchange Gain (Loss)
-0-00---
Other Non Operating Income (Expenses)
-4.23-0.06-0.06-0.06-0.06-0.1
EBT Excluding Unusual Items
-39.17-30.8116.8610.84-79.7551.35
Impairment of Goodwill
-----16.16-
Gain (Loss) on Sale of Investments
-0.94--1.38-1.44--
Gain (Loss) on Sale of Assets
0.120.123.590.01-0.02-
Asset Writedown
0.77-0.03-0-0-0.01-0
Other Unusual Items
5.994.632.114.415.243.95
Pretax Income
-33.23-26.0821.1713.81-90.7155.3
Income Tax Expense
0.750.7510.275.36-14.591.98
Earnings From Continuing Operations
-33.98-26.8310.898.45-76.1253.32
Minority Interest in Earnings
4.722.81-0.09-0.170.140.75
Net Income
-29.26-24.0210.88.28-75.9854.06
Net Income to Common
-29.26-24.0210.88.28-75.9854.06
Net Income Growth
--30.48%---44.24%
Shares Outstanding (Basic)
126126126126126126
Shares Outstanding (Diluted)
126126126126126126
Shares Change
-0.01%-0.00%0.03%-0.05%-0.00%0.00%
EPS (Basic)
-0.23-0.190.090.07-0.600.43
EPS (Diluted)
-0.23-0.190.090.07-0.600.43
EPS Growth
--30.44%---44.24%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
39.46-6.15.45-54.07-48.76-21.31
Free Cash Flow Per Share
0.31-0.050.04-0.43-0.39-0.17
Dividend Per Share
--0.0650.065--
Dividend Growth
--0%-74.00%--
Gross Margin
68.33%67.72%68.37%65.49%49.41%63.94%
Operating Margin
-10.57%-8.63%4.46%2.76%-24.93%10.43%
Profit Margin
-9.09%-7.02%2.67%1.96%-23.46%11.72%
Free Cash Flow Margin
12.25%-1.78%1.35%-12.81%-15.06%-4.62%
EBITDA
-21.04-15.6733.0224.33-66.9760.9
EBITDA Margin
-6.53%-4.58%8.18%5.76%-20.68%13.21%
D&A For EBITDA
12.9913.8615.0212.6713.7612.78
EBIT
-34.03-29.531811.66-80.7248.12
EBIT Margin
-10.57%-8.63%4.46%2.76%-24.93%10.43%
Effective Tax Rate
--48.53%38.81%-3.58%
Revenue as Reported
90.37342.02403.8422.17323.81461.21
Advertising Expenses
-25.6924.3431.3527.2816.48